Cite
HARVARD Citation
Lontai, L. et al. (n.d.). P578 Non-medical switch between adalimumab biosimilars and from the originator adalimumab to biosimilars in inflammatory bowel disease patients – a multicentre study on efficacy and drug sustainability. Journal of Crohn's and colitis. pp. i518-i519. [Online].